Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics

Title
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
Authors
Keywords
Biomarkers, Plasma proteins, Pancreatic cancer, Adiponectin, Enzyme-linked immunoassays, Hepatocellular carcinoma, Cancer detection and diagnosis, Proteomics
Journal
PLoS One
Volume 11, Issue 8, Pages e0161009
Publisher
Public Library of Science (PLoS)
Online
2016-09-01
DOI
10.1371/journal.pone.0161009

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search